About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Egln1tm2Fong
targeted mutation 2, Guo-Hua Fong
MGI:3778917
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Egln1tm2Fong/Egln1tm2Fong
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
involves: 129S6/SvEvTac * C57BL/6 MGI:3783535
cn2
Egln1tm2Fong/Egln1tm2Fong
Egln2tm2Fong/Egln2tm2Fong
Egln3tm2Fong/Egln3tm2Fong
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
involves: 129S6/SvEvTac * C57BL/6NCr * CD-1 MGI:5432008


Genotype
MGI:3783535
cn1
Allelic
Composition
Egln1tm2Fong/Egln1tm2Fong
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Egln1tm2Fong mutation (1 available); any Egln1 mutation (22 available)
Gt(ROSA)26Sortm1(cre/ERT2)Alj mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• reach 90% lethality by about 90 days after tamoxifen treatment
• mice begin to die 40 days after tamoxifen treatment with 90% lethality by about 90 days after treatment

cardiovascular system
• about 6 weeks after tamoxifen treatment major vascular branches of the ear are dilated and reddened and medium-sized blood vessels are scattered in the subendocardial layer
• after tamoxifen treatment, liver sections show an increase in large vessels
• after tamoxifen treatment the trachea contains more capillaries which are more branched and enlarged
• after tamoxifen treatment capillaries amid cardiac fibers are enlarged as are capillaries in the renal glomeruli
• dilated vessels and enlarged glomerular capillaries after tamoxifen treatment
• sinusoids are dilated after tamoxifen treatment
• after tamoxifen treatment the size and number of blood vessels in the lung is increased
• after tamoxifen treatment increased numbers of blood vessels are seen in the dermal and subcutaneous layers of the ear, the trachea contains more capillaries which are more branched and enlarged, more medium sized vessels are present in the subendocardial layer of the heart, and more vessels are seen in the liver and brain
• about 6 weeks after tamoxifen treatment vessels in the ear, trachea, heart, lung, kidney cortex and glomeruli, liver
• in the lung vessel dilation is accompanied by packed erythrocytes
• in the liver central veins are about 4-times larger than in controls

hematopoietic system
• significant increase in hematopoietic stem cells in the liver and spleen after tamoxifen treatment
• increase in the number of colonies formed by spleen and liver cells in a methylcellulose colony forming assay after tamoxifen treatment
• after tamoxifen treatment
• dramatic increase after tamoxifen treatment
• after tamoxifen treatment
• after tamoxifen treatment
• increase in the number of erythroid progenitor and myeloid cells after tamoxifen treatment

liver/biliary system
• more strongly colored than controls after tamoxifen treatment
• sinusoids are dilated after tamoxifen treatment

renal/urinary system
• dilated vessels and enlarged glomerular capillaries after tamoxifen treatment
• glomeruli are enlarged and their capillaries are dilated

homeostasis/metabolism
• 230-fold increase in serum erythropoietin levels within 2 weeks of tamoxifen treatment

immune system
• after tamoxifen treatment
• increase in the number of erythroid progenitor and myeloid cells after tamoxifen treatment

respiratory system
• after tamoxifen treatment the size and number of blood vessels in the lung is increased

integument
• erythemia is more apparent than in Egln2tm1Fong Egln3tm1Fong double homozygotes

growth/size/body




Genotype
MGI:5432008
cn2
Allelic
Composition
Egln1tm2Fong/Egln1tm2Fong
Egln2tm2Fong/Egln2tm2Fong
Egln3tm2Fong/Egln3tm2Fong
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6NCr * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Egln1tm2Fong mutation (1 available); any Egln1 mutation (22 available)
Egln2tm2Fong mutation (1 available); any Egln2 mutation (18 available)
Egln3tm2Fong mutation (1 available); any Egln3 mutation (26 available)
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory